focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,172.00
Bid: 11,500.00
Ask: 12,470.00
Change: 0.00 (0.00%)
Spread: 970.00 (8.435%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,172.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: UK stocks flat ahead of US data, Fed decision

Wed, 30th Jul 2014 11:42

- Corporate earnings receive mixed market reaction- Barclays, Travis Perkins and Astra rise- Antofagasta, ITV and Compass fall- US data, Fed decision in focus later ontechMARK 2,783.73 +0.05%FTSE 100 6,803.99 -0.06%FTSE 250 15,675.20 -0.08%The FTSE 100 was trading broadly flat on Wednesday, teetering at the 6,800 level, as investors gave a mixed reaction to a flurry of corporate earnings and awaited key economic data from the States.Meanwhile, traders were still watching developments in the Ukraine crisis after US and EU leaders announced a fresh round of sanctions on Russia yesterday. Relentless fighting in Gaza and a potential debt default in Argentina were also likely to be weighing on risk appetite.London's benchmark index was 0.1% lower at 6,804 by midday as strong gains from Barclays, Travis Perkins and AstraZeneca were offset by falls from Antofagasta, ITV and Compass.After a relatively quiet start to the week on the macro calendar, things will pick up this afternoon with the focus on the closely-watched ADP employment report and second-quarter gross domestic product (GDP) estimates in the States, as well as the Federal Reserve's policy decision scheduled for this evening.The consensus forecast is for annualised US GDP growth to be 3% in the second quarter of 2014, a sharp rebound from the 2.9% contraction registered in the first quarter.As for the Fed, there will not be a press conference but the central bank's statement is likely to have a "dovish twist", according to analysts at Danske Bank, "giving an acknowledgement that the labour market is improving faster than expected". Barclays leads banks higherBarclays was up 4% as it reported a less-than-expected 12% fall in total income adjusted for insurance claims for the first half to £13.32bn, driven by reductions at its investment and African banking units. The consensus estimate had been for a drop to £13.23bn. Domestic banking peers RBS and Lloyds were also on the rise.Housebuilder Travis Perkins also impressed as it reported double-digit growth across the board in the first half, with like-for-like revenues up 10.2% and profits up 16%. The company said it expects "continued solid growth" for the rest of the year.Astrazeneca was in demand after it struck a deal with drug developer Almirall for the rights to the Spanish group's respiratory franchise. The initial consideration is $875m.Chile-focused mining group Antofagasta underwhelmed as it maintained its production guidance for 2014 after a sequential increase in output in the second quarter, while net cash costs were broadly flat. Shares of broadcaster ITV were in negative territory with the stock retreating after its recent strong run. Nevertheless, the company managed to beat expectations with its first-half results this morning with pre-tax profits up 16%.Catering and facilities management giant Compass served up a healthy third quarter of trading, improving margin across the group as revenue growth in North America remained strong while Europe and Japan improved. On the FTSE 250, retailer Pets at Home jumped after new store openings and strength in the food, accessories and services categories drove first-quarter revenues 10.4% higher.FTSE 100 - RisersBarclays (BARC) 228.10p +4.11%Travis Perkins (TPK) 1,700.00p +3.34%Royal Bank of Scotland Group (RBS) 361.60p +2.15%Capita (CPI) 1,238.00p +1.89%Carnival (CCL) 2,157.00p +1.41%Lloyds Banking Group (LLOY) 76.65p +1.35%Reckitt Benckiser Group (RB.) 5,280.00p +1.15%AstraZeneca (AZN) 4,362.00p +0.91%BAE Systems (BA.) 428.80p +0.78%BT Group (BT.A) 389.40p +0.62%FTSE 100 - FallersAntofagasta (ANTO) 834.00p -2.46%Sainsbury (J) (SBRY) 317.00p -1.95%Aberdeen Asset Management (ADN) 423.00p -1.79%ITV (ITV) 201.90p -1.51%Compass Group (CPG) 994.50p -1.34%BHP Billiton (BLT) 2,069.00p -1.29%GKN (GKN) 361.30p -1.28%3i Group (III) 388.60p -1.22%Morrison (Wm) Supermarkets (MRW) 172.40p -1.20%Ashtead Group (AHT) 920.50p -1.18%FTSE 250 - RisersPets at Home Group (PETS) 180.10p +5.94%Moneysupermarket.com Group (MONY) 189.60p +4.18%National Express Group (NEX) 265.10p +3.27%Cairn Energy (CNE) 182.80p +2.47%Diploma (DPLM) 640.00p +2.40%Bwin.party Digital Entertainment (BPTY) 87.90p +2.15%Phoenix Group Holdings (DI) (PHNX) 707.50p +2.02%PayPoint (PAY) 1,073.00p +2.00%Thomas Cook Group (TCG) 122.10p +2.00%Riverstone Energy Limited (RSE) 921.50p +1.82%FTSE 250 - FallersPace (PIC) 345.50p -4.53%International Personal Finance (IPF) 565.50p -3.50%Jupiter Fund Management (JUP) 401.70p -3.23%Just Eat (JE.) 205.10p -2.33%CSR (CSR) 538.00p -2.00%Hochschild Mining (HOC) 163.70p -1.98%Big Yellow Group (BYG) 500.50p -1.86%Infinis Energy (INFI) 235.80p -1.75%Dixons Retail (DXNS) 51.00p -1.73%Carphone Warehouse Group (CPW) 329.30p -1.70%BC
More News
1 Dec 2023 08:52

LONDON MARKET OPEN: Miners give FTSE 100 boost thanks to China PMI

(Alliance News) - Stock prices in London opened higher on Friday, with the FTSE 100 boosted by mining stocks.

Read more
1 Dec 2023 08:33

AstraZeneca discontinues two phase III evidence trials for Lokelma

(Alliance News) - AstraZeneca on Friday said it has decided to discontinue the Stabilize-CKD and Dialize-outcomes phase III trials for Lokelma, citing increased enrolment timelines.

Read more
1 Dec 2023 08:01

AstraZeneca calls off two phase III trials into hyperkalaemia treatment

(Sharecast News) - Drugmaker AstraZeneca has called off two phase III trials on its hyperkalaemia treatment after a series of logistical challenges.

Read more
1 Dec 2023 07:41

LONDON BRIEFING: Stocks called higher; UK house prices fall annually

(Alliance News) - Stocks in London are called to open higher on Friday, following data from Nationwide showing that the annual pace of UK house price decline slowed in November.

Read more
27 Nov 2023 16:12

London close: Stocks start week in subdued state

(Sharecast News) - London's financial markets saw a somewhat subdued performance on Monday, as concerns regarding the Chinese economy cast a shadow over investor sentiment.

Read more
27 Nov 2023 09:20

LONDON BROKER RATINGS: Peel, Numis up Rightmove; Goldman cuts Entain

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
23 Nov 2023 18:41

IN BRIEF: AstraZeneca Chair Demare buys shares for over GBP200,000

AstraZeneca PLC - Cambridge-based pharmaceutical company - Chair Michel Demare buys 2,000 shares in total on Wednesday and Tuesday. Buys 1,000 shares for GBP101.05 each on Tuesday and 1,000 shares for GBP101.70 each on Thursday, for a total of GBP202,752.

Read more
20 Nov 2023 10:49

AstraZeneca launches new life sciences tech innovation firm Evinova

(Alliance News) - AstraZeneca PLC on Monday launched Evinova, a new health technology business focused on accelerating innovation across the life sciences sector, delivery of clinical trials and better health outcomes.

Read more
17 Nov 2023 15:20

London close: Stocks higher despite weaker retail sales data

(Sharecast News) - London's stock markets finished in a positive state on Friday despite weaker-than-expected UK retail sales figures.

Read more
17 Nov 2023 12:00

LONDON MARKET MIDDAY: Stocks shrug off downbeat UK retail sales

(Alliance News) - Stock prices in London were up at midday on Friday, as a week of favourable data as far as inflation goes gave investors a reason to overlook disappointing UK retail sales figures.

Read more
17 Nov 2023 09:03

LONDON MARKET OPEN: Stocks up despite UK retail sales growth miss

(Alliance News) - Stock prices in London opened higher on Friday, despite weaker-than-expected October retail sales figures for the UK.

Read more
17 Nov 2023 08:31

TOP NEWS: US approves AstraZeneca's Truqap for form of breast cancer

(Alliance News) - AstraZeneca PLC on Friday said that the US Food & Drug Administration approved its drug Truqap in combination with Faslodex to treat patients with an advanced form of breast cancer.

Read more
17 Nov 2023 07:58

LONDON BRIEFING: UK retail sales fall; AstraZeneca gets US approval

(Alliance News) - Stock prices in London are still set to open higher on Friday, despite October retail sales figures for the UK disappointing shortly before the opening bell.

Read more
17 Nov 2023 07:16

AstraZeneca gets US approval for breast cancer treatment

(Sharecast News) - AstraZeneca's 'Truqap', or capivasertib, in combination with 'Faslodex', or fulvestrant, has secured approval from the US Food and Drug Administration (FDA) for specific breast cancer treatments, the company announced on Friday.

Read more
14 Nov 2023 10:51

TOP NEWS: AstraZeneca Imfinzi fails to meet endpoint in cancer trial

(Alliance News) - AstraZeneca PLC on Tuesday said the Pacific-2 phase III trial for Imfinzi as an early treatment lung cancer immunotherapy treatment administered with chemoradiotherapy, did not meet its primary endpoint.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.